Related Experiment Video
Updated: Jul 11, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Tagged fragment method for evolutionary structure-based de novo lead generation and optimization
Qian Liu1, Brian Masek, Karl Smith
1Tripos, Inc., 1699 South Hanley Road, St. Louis, Missouri 63144, USA. qliu@tripos.com
Abstract:
Here we describe a computer-assisted de novo drug design method, EAISFD, which combines the de novo design engine EA-Inventor with a scoring function featuring the molecular docking program Surflex-Dock. This method employs tagged fragments, which are preserved substructures in EA-Inventor used for base fragment matching in Surflex-Dock, for constructing ligand structures under specific binding motifs. In addition, a target score mechanism is adopted that allows EAISFD to deliver a diverse set of desired structures. This method can be used to design novel ligand scaffolds (lead generation) or to optimize attachments on a fixed scaffold (lead optimization). EAISFD has successfully suggested many known inhibitor scaffolds as well as a number of new scaffold types when applied to p38 MAP kinase.
Related Concept Videos
Genome Annotation and Assembly
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Evolutionary Relationships through Genome Comparisons
Tagging and Fusion Proteins
Drug Discovery: Overview

